Sjogren's syndrome (SS) may occur in the absence (primary SS) or presence (secondary SS) of other autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, or primary biliary cirrhosis.' Clinically it is characterised by the presence of keratoconjunctivitis sicca, xerostomia, and, in 80% of patients, intermittent uni- or On examination the patient had Cushingoid facies, a few splinter haemorrhages, fading purpuric lesions on the lower legs, and peripheral sensory loss in a stocking distribution. There was no evidence of inflammatory arthropathy, hepatosplenomegaly, or lymphadenopathy. The lacrimal and salivary glands were not enlarged, but the buccal mucosa was dry and glazed with sticky saliva. Schirmer's test was abnormal (at five minutes 0 mm/right eye, 5 mm/left eye; normal >15 mm).
The complete blood picture and plasma biochemistry were normal, ESR 60 mm/lst h, and antinuclear factor negative (titre 1/10; normal <1/40). Antibodies to extractable nuclear antigen, Ro(SS-A) and La(SS-B), were absent. Rheumatoid factor was detected by latex agglutination but not by the Rose-Waaler test. Cryoglobulins (3.3 g/l) were detected, which were shown by immunofixation to consist of polyclonal IgG and a monoclonal IgM kappa paraprotein (type II cryoglobulinaemia).
After fractionation of the serum on a Sepharose 6B column (90 x 2-5 cm) the rheumatoid factor activity was found to coelute with the pentameric IgM peak. Rheumatoid factor activity in each fraction was detected by two methods: a nephelometric method employing human aggregated IgG as substrate and a latex agglutination method. A second peak of low molecular weight IgM was also noted, which did not contain rheumatoid factor activity. Fractionation of serum after removal of cryoprecipitate resulted in complete loss of rheumatoid factor activity from the IgM fraction. Blood viscosity was normal. Complement studies on warm serum showed C3=0 59 g/l (0-5-1-5), C4<0-01 g/l (0.2-0.5), and total haemolytic complement <40% (normal>90%). Lip biopsy showed generalised sialadenitis and lymphoid infiltrate consistent with Sjogren's syndrome. A bone marrow aspirate showed iron deficiency and increased T4/T8 lymphocyte subset ratio but no evidence of Waldenstrom's macroglobulinaemia. Urinary Bence-Jones protein was not detected.
On the basis of these features a diagnosis was made of primary SS associated with necrotising vasculitis, mixed cryoglobulinaemia, and IgM kappa paraproteinaemia. Subsequent management has been directed at symptomatic therapy of sicca symptoms and control of vasculitis with cyclophosphamide (100 mg/day) and prednisolone (7 mg/day). Plasmapheresis was considered but not used in this patient.
Discussion
The patient we describe has primary SS complicated by vasculitis and cryoglobulinaemia with an IgM kappa paraproteinaemia. The positive latex screening test for rheumatoid factor, the presence of monoclonal IgM with polyclonal IgG in the cryoglobulin, the coelution of rheumatoid factor activity with IgM on fractionation of serum, and loss of rheumatoid factor from serum after removal of the cryoprecipitate each provide evidence that the IgM paraprotein has rheumatoid factor specificity.
There is no consensus regarding optimal management of cryoglobulinaemia. Corticosteroids control the inflammatory effects of cryoglobulin deposition but have no effect on cryoglobulin levels. 
